Physician profile
Neil E Gordon
NPI 1376512301
$1,658.87
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $751 · 2020: $396 · 2021: $318 · 2023: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $194.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $395.27 | 2019 | |
| Abbvie INC. | $342.68 | 2021-2023 | |
| Allergan, INC. | $303.86 | 2019-2020 | |
| Pfizer INC. | $125.24 | 2019-2023 | |
| Amgen INC. | $115.36 | 2019 | |
| Lilly USA, LLC | $65.80 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $29.69 | 2019-2020 | |
| Shire North American Group INC | $28.94 | 2019 | |
| Sanofi-Aventis U.S. LLC | $28.28 | 2023 | |
| Glaxosmithkline, LLC. | $26.40 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $25.71 | 2020 | |
| Astellas Pharma US INC | $21.45 | 2019 | |
| Amarin Pharma, INC. | $21.36 | 2019 | |
| Lantheus Medical Imaging, INC. | $20.55 | 2021 | |
| Exact Sciences Corporation | $20.49 | 2023 | Cologuard Collection Kit |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $20.37 | 2023 | Yupelri |
| Novo Nordisk INC | $20.22 | 2020 | |
| Dexcom, INC. | $17.40 | 2023 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $16.88 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $12.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.